Type
. [Dermopathy and peripheral neuropathy]. Enfermedades infecciosas y microbiologia clinica. 2005;23(10):629-30.
Type
. Ethical issues considered in Tamil Nadu leprosy vaccine trial. Issues in medical ethics. 2000;8(1):10-2.
Type
. Leprosy: contribution of mast cells to epineurial collagenization. Clinical neuropathology. 2005;24(6):284-90.
Type
. Prevention of blindness in leprosy and the role of the Vision 2020 Programme. Eye (London, England) [Internet]. 2005;19(10):1099-105. Available from: http://www.nature.com/eye/journal/v19/n10/pdf/6701984a.pdf
Type
. [Serological tests in the diagnosis of tuberculosis]. Biomedica : revista del Instituto Nacional de Salud. 2005;25(3):422-3; author reply 423-4.
Type
. [Dermatologic manifestations associated with immune reconstitution syndrome in HIV+ patients starting HAART: a retrospective study in French Guiana]. Bulletin de la Societe de pathologie exotique (1990). 2005;98(3):187-92.
Type
. [Effect of physician shortage on today's Hansen's disease management]. Nihon Hansenbyo Gakkai zasshi = Japanese journal of leprosy : official organ of the Japanese Leprosy Association. 2005;74(3):221-5.
Type
. [Survey on the present conditions of the residents regarding aging, aftereffects and subsequent complication]. Nihon Hansenbyo Gakkai zasshi = Japanese journal of leprosy : official organ of the Japanese Leprosy Association. 2005;74(3):211-9.
Type
. [Pathological diagnosis of leprosy in developing countries]. Nihon Hansenbyo Gakkai zasshi = Japanese journal of leprosy : official organ of the Japanese Leprosy Association. 2005;74(3):191-8.
Type
. Services for leprosy related 'distress': another perspective. Leprosy review [Internet]. 2005;76(3):263-4. Available from: https://leprosyreview.org/article/76/3/26-3264